NCT03425617View on ClinicalTrials.gov

Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Tiotropium + Olodaterol

tiotropium 5 mcg plus olodaterol 5 mcg via Respimat® single dose

OTHER

PLACEBO

PLACEBO via Respimat® single dose

Trial Locations (1)

k7l2v7

Kingston General Hospital, Kingston

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Queen's University

OTHER